No Data
The guidelines for the resumption of trading of zensun ent (00185.HK) have all been met.
Zensun ent (00185.HK) announced that all resumption guidelines have been met, including the publication of all outstanding financial results and addressing any audit reservations; proving that the company complies with Listing Rule 13.24, which requires having sufficient assets to support operations; and informing the market of all significant information. The company's shares have been suspended from trading since April 2 and have applied for resumption of trading on Thursday (28th).
Zensun ent (00185.HK) has reached the resumption guidelines and plans to resume trading on November 28.
zensun ent announced on November 27th that the company is pleased to inform its shareholders and potential investors that as of the date of this announcement, all resumption guidelines have been reached. The company has applied to the Hong Kong Stock Exchange for the resumption of trading of the company's shares (stock code: 185) and debt securities (code: 5862) starting from 9:00 am on Thursday, November 28, 2024.
Many real estate stocks surged by over 60%! On the first day of the new policies in Beijing, Shanghai, Guangzhou, and Shenzhen, some people even "bought houses in the air" overnight!
After the opening of the Hong Kong stock market, the real estate sector has the highest increase, with more than several individual stocks still rising by over 60% as of the time of writing.
Zensun ent (00185.HK): Continuing suspension for the preparation of the 2023 annual report and 2024 interim report.
Zensun ent (00185.HK) announced that it is currently working closely with its auditors to prepare the 2023 annual report and the 2024 interim report. In addition, as of this Monday (September 30), despite the suspension of trading in the company's shares, the zensun ent's business operations are proceeding as usual in all major aspects. At the request of zensun ent, its shares and debt securities have been suspended from trading on the stock exchange since April 2 this year, and will continue to be suspended until further notice.
In 2023, zensun ent (00185.HK) narrowed its loss to 2.298 billion RMB.
Zensun Ent (00185.HK) announced its financial performance for the year ended 2023, with revenue recorded at 20.035 billion RMB (same below), an increase of 107.5% year-on-year. The loss narrowed from 2.946 billion yuan in the previous year to 2.298 billion yuan, with a loss per share of 120.1 cents. No dividend was distributed. Trading of the company's shares has been suspended since April 2nd and will continue to be halted.
Zensun Ent (00185) announced its interim results, with a net loss attributable to owners of approximately 1.597 billion yuan, an increase of about 326.5% year-on-year.
Zensun Ent (00185) announced its 2024 interim performance, with earnings of approximately RMB 0.184 billion, an increase of 26.70% compared to 202...
No Data
No Data